Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65576 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Celecoxib Carboxylic Acid (4-[1-[4-(Aminosulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoic Acid)
CAS :Couleur et forme :NeatPK-11195
CAS :<p>M02235 - PK-11195</p>Formule :C21H21ClN2ODegré de pureté :>98%Couleur et forme :SolidMasse moléculaire :352.861-(4-Methoxyphenyl)-2-quinolin-2-ylethanone
CAS :Degré de pureté :95.0%Masse moléculaire :277.322998046875Perfluorophenyl 4-(5-(trifluoromethyl)pyridin-2-yl)benzoate
CAS :Degré de pureté :98%Masse moléculaire :433.2569885253906Perfluorophenyl 6-((tetrahydro-2H-pyran-4-yl)oxy)nicotinate
CAS :Degré de pureté :98%Masse moléculaire :389.27801513671875Chlorcyclizine Hydrochloride 1.0 mg/ml in Methanol (as free base)
CAS :Couleur et forme :Single Solution(2-Amino-benzothiazol-6-yl)-morpholin-4-yl-methanone
CAS :Degré de pureté :95+%Couleur et forme :SolidMasse moléculaire :263.320007324218753-Amino-2-phenylindenone
CAS :Degré de pureté :98.0%Couleur et forme :SolidMasse moléculaire :221.25900268554688Vortioxetine-D8.HBr, 0.1mg/ml in Methanol (as free base)
Formule :C18D8H14N2S·BrHCouleur et forme :Single Solution1-(4-Methoxyphenyl)-2-quinoxalin-2-yl ethanol
CAS :Degré de pureté :95.0%Masse moléculaire :280.32699584960944-Chloro-2-pyridin-2-yl-6-pyridin-3-ylpyrimidine
CAS :Degré de pureté :95.0%Masse moléculaire :268.700012207031252-Pyridin-3-yl-1 H -benzoimidazol-5-ylamine
CAS :Degré de pureté :98+%Couleur et forme :SolidMasse moléculaire :210.24000549316406d,l-Methylphenidate.HCl, 1mg/ml in Methanol (as free base)
CAS :Produit contrôléCouleur et forme :Single Solution2-Amino-4-biphenyl-4-yl-thiophene-3-carboxylic acid methyl ester
CAS :Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :309.3800048828125Flunarizine Dihydrochloride 1.0 mg/ml in Methanol (as free base)
CAS :Couleur et forme :Single Solution6-Bromo-2-(2,5-dimethyl-thiophen-3-yl)-quinoline-4-carboxylic acid
CAS :Couleur et forme :SolidMasse moléculaire :362.239990234375Perfluorophenyl 2-thiomorpholinoisonicotinate
CAS :Degré de pureté :98%Masse moléculaire :390.32998657226562-(1H-Pyrazol-4-yl)quinoxaline
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :196.21299743652344Aripiprazole metabolite-D6 (OPC-3373-D6), 0.1mg/ml in Ethanol
Formule :C13D6H9NO4Couleur et forme :Single Solution2-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(2-chlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White PowderMasse moléculaire :275.08437Carvedilol Related Compound E (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C9H13NO2Couleur et forme :Off-White PowderMasse moléculaire :167.094634-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C17H21N·HClCouleur et forme :White Off-White SolidMasse moléculaire :239.1674Ambrisentan R-Enantiomer ((R)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C22H22N2O4Couleur et forme :White Fine PowderMasse moléculaire :378.15796Argatroban
CAS :Sulfonamides used as drugsFormule :C23H36N6O5S·H2OCouleur et forme :White Off-White PowderMasse moléculaire :526.25735Rotigotine Related Compound K (7,8-Dihydronaphthalen-1-ol)
CAS :Monophenols not elsewhere specified or includedFormule :C10H10OCouleur et forme :White Grey Brown Crystalline SolidMasse moléculaire :146.07316Darunavir Ethanolate
CAS :Sulfonamides used as drugsFormule :C27H37N3O7S·C2H6OCouleur et forme :White Beige PowderMasse moléculaire :593.27709Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C16H13N3O2SCouleur et forme :Dark Brown PowderMasse moléculaire :311.07285Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29ClN4O5Couleur et forme :Off-White PowderMasse moléculaire :524.18265Dichloroaniline (3,4-Dichloroaniline)
CAS :Aniline derivatives and their saltsFormule :C6H5Cl2NCouleur et forme :Light Brown Off-White CrystalsMasse moléculaire :160.9799Methylparaben
CAS :Carboxylic acids with phenol function but without otherFormule :C8H8O3Couleur et forme :White Crystalline PowderMasse moléculaire :152.154-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4'-Methylacetophenone))
CAS :Aromatic ketones without other oxygen function, nesoiFormule :C9H10OCouleur et forme :Colorless LiquidMasse moléculaire :134.07316N-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormule :C15H24N2O4Couleur et forme :Colorless LiquidMasse moléculaire :296.17361Refined Bleached Shellac
CAS :Natural gums, gum resins, resins and balsams nesoiCouleur et forme :PowderNilotinib Related Compound A (3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C11H10F3N3Couleur et forme :Beige PowderMasse moléculaire :241.08268S-Levetiracetam Hydroxybutyramide Analog ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H16N2O3Couleur et forme :White Off-White SolidMasse moléculaire :188.11609Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H12N2O2Couleur et forme :White PowderMasse moléculaire :216.08988Amiodarone Related Compound E ((2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H18O3Couleur et forme :White Brown PowderMasse moléculaire :294.12559Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H41N7O5Couleur et forme :PowderMasse moléculaire :627.31692Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Fluconazole Related Compound C (1,1'-(1,3-phenylene)di(1H-1,2,4-triazole))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C10H8N6Couleur et forme :White PowderMasse moléculaire :212.081044-Chloro Omeprazole (2-[(RS)-[4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H16ClN3O2SCouleur et forme :Off-White SolidMasse moléculaire :349.06518Benzyl Alcohol
CAS :Benzyl alcohol (alpha-hydroxytoluene; phenyl-methanol)Formule :C7H8OCouleur et forme :Colorless Clear LiquidMasse moléculaire :108.14 g/molSucralose
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C12H19Cl3O8Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :396.01455N-Isopropyl Carvedilol (1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C27H32N2O4Couleur et forme :Off-White SolidMasse moléculaire :448.23621Metoprolol Related Compound A ((+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C14H23NO3Couleur et forme :White Clumpy PowderMasse moléculaire :253.16779Fluconazole Related Compound B (2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H13FN6OCouleur et forme :White PowderMasse moléculaire :288.11349Rotigotine Related Compound H ((S)-5-Methoxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H27NOSCouleur et forme :Light Brown LiquidMasse moléculaire :329.18134O-Thienylethyl Rotigotine Hydrochloride ((S)-N-propyl-5-(2-(thiophen-2-yl)ethoxy)-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C25H32ClNOS2Couleur et forme :Pale Beige SolidMasse moléculaire :461.16138Duloxetine Related Compound F ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :Off-White PowderMasse moléculaire :333.09541Carvedilol Related Compound A (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C36H43N3O7Couleur et forme :PowderMasse moléculaire :629.3101Clioquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5ClINOCouleur et forme :PowderMasse moléculaire :304.91044Nadolol Related Compound A ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
CAS :Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C13H18O5Couleur et forme :White SolidMasse moléculaire :254.11542Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H18O4Couleur et forme :White Coarse Powder Semi-SolidMasse moléculaire :226.12051Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196Atazanavir System Suitability Mixture (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer)
Compounds containing an unfused pyridine ring in the structure, nesoiCouleur et forme :White Light Yellow Crystalline PowderCrospovidone
CAS :Other vinyl polymers in primary forms,nesoiFormule :(C6H9NO)nCouleur et forme :White Off-White PowderMasse moléculaire :177.121Rotigotine Racemate ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :Off-White CrystalsMasse moléculaire :315.16569Methyl Alcohol
CAS :Methanol (methyl alcohol)Formule :CH4OCouleur et forme :Colorless Clear LiquidMasse moléculaire :32.02621Topiramate Related Compound A (2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C12H20O6Couleur et forme :White PowderMasse moléculaire :260.12599Rotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :White Beige PowderMasse moléculaire :315.16569Rotigotine Hydrochloride Ethyl Analog ((S)-6-(ethyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H24ClNOSCouleur et forme :Beige SolidMasse moléculaire :337.12671Aleuritic Acid
CAS :Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormule :C16H32O5Couleur et forme :PowderMasse moléculaire :304.22497R-Levetiracetam Hydroxybutyramide Analog ((R)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H16N2O3Couleur et forme :White Off-White SolidMasse moléculaire :188.11609Anastrozole Diacid (2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanoic acid))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H21N3O4Couleur et forme :Off-White SolidMasse moléculaire :331.15321Amiodarone Hydrochloride
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H29I2NO3·HClCouleur et forme :White PowderMasse moléculaire :681.78 g/molRivaroxaban Related Compound J
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C38H36Cl2N6O10S2Couleur et forme :Off-White PowderMasse moléculaire :870.13114Nadolol
CAS :Aromatic drugs of amino-alcohols, other than those contFormule :C17H27NO4Couleur et forme :White PowderMasse moléculaire :309.4 g/molAtazanavir S,R,S,S-diastereomer ((3S,8R,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C38H52N6O7Couleur et forme :White Off-White SolidMasse moléculaire :704.38975Fluvoxamine Maleate
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C15H21F3N2O2·C4H4O4Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :318.15551Teriflunomide Related Compound B (2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide)
CAS :Nitrile function compounds, nesoiFormule :C10H7F3N2OCouleur et forme :White Yellow Crystalline PowderMasse moléculaire :228.05105Oxcarbazepine Related Compound E (10(11H)-Oxo-5H-dibenz[b,f]azepine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H11NOCouleur et forme :PowderMasse moléculaire :209.08406Labetalol Hydrochloride
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C19H24N2O3·HClCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :364.15537Brivaracetam Related Compound C ((R)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS :Lactams, nesoiFormule :C11H20N2O2Couleur et forme :White SolidMasse moléculaire :212.15248Metoprolol Related Compound C (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C13H19NO3·HClCouleur et forme :White PowderMasse moléculaire :237.13649Methoxy Carbamazepine (10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H14N2O2Couleur et forme :White Off-White SolidMasse moléculaire :266.10553Labetalol Related Compound F (2-Hydroxy-5-[(4-phenylbutan-2-yl)glycyl]benzamide hydrochloride)
CAS :<p>Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof</p>Formule :C19H22N2O3·HClCouleur et forme :White Off-White PowderMasse moléculaire :362.13972Ondansetron Hydrochloride
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H19N3O·HCl·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Prasugrel Hydrochloride (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H20FNO3S·HClCouleur et forme :White Off-White PowderMasse moléculaire :409.09147Iodoquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5I2NOCouleur et forme :Light Brown Yellow PowderMasse moléculaire :396.84606Norepinephrine Bitartrate
CAS :Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormule :C8H11NO3·C4H6O6·H2OCouleur et forme :White Light Grey Crystalline PowderMasse moléculaire :337.1009Clozapine Benzoyl Methylpiperazine Analog (1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C18H21ClN4OCouleur et forme :Beige PowderMasse moléculaire :344.14039Dofetilide
CAS :Sulfonamides used as drugsFormule :C19H27N3O5S2Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :441.13921Carvedilol System Suitability Mixture (carvedilol spiked with carvedilol related compound F)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderEzetimibe
CAS :Lactams, nesoiFormule :C24H21F2NO3Couleur et forme :White PowderMasse moléculaire :409.14895Fluvoxamine Z-isomer Maleate ((Z)-5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C15H21F3N2O2·C4H4O4Couleur et forme :White SolidMasse moléculaire :318.15551Labetalol Cyclohexyl Analog (5-{2-[(4-Cyclohexylbutan-2-yl)amino]-1-hydroxyethyl}-2-hydroxybenzamide hydrochloride)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C19H30N2O3·HClCouleur et forme :White PowderMasse moléculaire :370.20232Paroxetine System Suitability Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White PowderAmbrisentan Related Compound B (2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C16H16O4Couleur et forme :Off-White PowderMasse moléculaire :272.10486Oxcarbazepine
CAS :Anticonvulsants, hypnotics and sedativesFormule :C15H12N2O2Couleur et forme :Off-White Cream Light Orange PowderMasse moléculaire :252.08988N-Nitroso Bupropion Solution (1 mL ) (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :LiquidMasse moléculaire :268.09786Naproxen Related Compound A (6-methoxy-2-naphthoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C12H10O3Couleur et forme :White Off-White PowderMasse moléculaire :202.06299Deschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H19NO·HClCouleur et forme :White PowderMasse moléculaire :241.123343-Acetamidophthalic acid (3-acetamidophthalic acid)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C10H9NO5Couleur et forme :Off-White SolidMasse moléculaire :223.04807Atazanavir Ditertbutyl Analog (tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazine-1-carboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H42N4O5Couleur et forme :Off-White SolidMasse moléculaire :562.31552Labetalol Related Compound A (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C19H23NO4·HClCouleur et forme :Off-White SolidMasse moléculaire :365.13939Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSHClCouleur et forme :White Off-White PowderMasse moléculaire :315.16569N-Nitroso Bupropion (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :SolidMasse moléculaire :268.09786Levetiracetam Racemic Mixture (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide)
CAS :Lactams, nesoiFormule :C8H14N2O2Couleur et forme :White Off-White PowderMasse moléculaire :170.10553Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C29H26ClN3O8SCouleur et forme :White Off-White SolidMasse moléculaire :611.11291Atazanavir amine analog methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-amino-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C36H50N6O5Couleur et forme :Off-White SolidMasse moléculaire :646.38427Bendroflumethiazide
CAS :Sulfonamides used as drugsFormule :C15H14F3N3O4S2Couleur et forme :PowderMasse moléculaire :421.42Saxagliptin
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H25N3O2·H2OCouleur et forme :White Off-White Light Brown Crystalline PowderMasse moléculaire :333.20524Nadolol Related Compound G (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C17H27NO2Couleur et forme :Off-White PowderMasse moléculaire :277.20418Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :Pale Yellow SolidMasse moléculaire :453.07613Dofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS :Sulfonamides, nesoiFormule :C18H25N3O5S2Couleur et forme :White PowderMasse moléculaire :427.12356Atazanavir Sulfate Valine Analog (methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15-methyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C37H50N6O7·H2SO4Couleur et forme :Off-White SolidMasse moléculaire :690.3741Dibenzazepinodione (5H-dibenzo[b,f]azepine-10,11-dione)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H9NO2Couleur et forme :Dark Orange SolidMasse moléculaire :223.06333Silodosin
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C25H32F3N3O4Couleur et forme :White Pale Yellow Crystalline PowderMasse moléculaire :495.234494-(Pyridin-2-yl)benzaldehyde (4-(Pyridin-2-yl)benzaldehyde)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H9NOCouleur et forme :Pale Yellow Off-White PowderMasse moléculaire :183.068415-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H5NO3Couleur et forme :White SolidMasse moléculaire :127.02694Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :421.12739Carbomer Homopolymer
CAS :Other acrylic polymers in primary forms (excluding elastomeric)Couleur et forme :White PowderBicalutamide Sulfide (N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylthio)-2-hydroxy-2-methylpropanamide)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C18H14F4N2O2SCouleur et forme :White PowderMasse moléculaire :398.07121Ondansetron
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C18H19N3OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Fesoterodine Fumarate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C26H37NO3·C4H4O4Couleur et forme :White Off-White PowderMasse moléculaire :527.2883Desmethoxyomeprazole
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H17N3O2SCouleur et forme :Light Brown Grey Yellow PowderMasse moléculaire :315.10415Plerixafor
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C28H54N8Couleur et forme :White Off-White PowderMasse moléculaire :502.44714Carvedilol Related Compound B (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C39H39N3O6Couleur et forme :Off-White PowderMasse moléculaire :645.28389Regorafenib
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H15ClF4N4O3·H2OCouleur et forme :White Brown PowderMasse moléculaire :500.08745Fluphenazine Enanthate Dihydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C29H38F3N3O2S·2HClCouleur et forme :PowderMasse moléculaire :549.26368Ambrisentan
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C22H22N2O4Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :378.15796Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N6O6Couleur et forme :White SolidMasse moléculaire :628.30093Saxagliptin Related Compound B (Saxagliptin amide analog (1S,3S,5S)-2-{(S)-2-Amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H27N3O3Couleur et forme :White Fine PowderMasse moléculaire :333.20524Metoprolol Dimer (1,3-Bis[4-(2-methoxyethyl)phenoxy]propan-2-ol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormule :C21H28O5Couleur et forme :Colorless Light Yellow LiquidMasse moléculaire :360.19367Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29BrN4O5Couleur et forme :Cream PowderMasse moléculaire :568.13213Imidazole (1H-Imidazole)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C3H4N2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :68.03745Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H13NOCouleur et forme :White Off-White PowderMasse moléculaire :211.09971Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C36H36N6O10Couleur et forme :Off-White SolidMasse moléculaire :712.24929Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
CAS :Nitrile function compounds, not elsewhere specified or includedFormule :C12H9F3N2O2Couleur et forme :White Off-White PowderMasse moléculaire :270.06161Sorafenib Formamide (4-(4-formamidophenoxy)-N-methylpicolinamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H13N3O3Couleur et forme :Off-White SolidMasse moléculaire :271.09569Butylated Hydroxytoluene
CAS :Monophenols, nesoiFormule :C15H24OCouleur et forme :White PowderMasse moléculaire :220.18272Brivaracetam Related Compound A ((S)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS :Lactams, nesoiFormule :C11H20N2O2Couleur et forme :White PowderMasse moléculaire :212.15248Ambrisentan Related Compound E (4,6-Dimethylpyrimidin-2-ol)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C6H8N2OCouleur et forme :White Off-White Pale Yellow Crystalline PowderMasse moléculaire :124.06366Regular Bleached Shellac
CAS :Natural gums, gum resins, resins and balsams nesoiCouleur et forme :PowderDesethylamiodarone (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C23H25I2NO3·HClCouleur et forme :White Off-White SolidMasse moléculaire :652.96907Salmeterol Xinafoate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C25H37NO4·C11H8O3Couleur et forme :White PowderMasse moléculaire :415.27226
![Celecoxib Carboxylic Acid (4-[1-[4-(Aminosulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-5-yl]benz…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F61%2Fthumb-webp%2FFOR0344.03.webp&w=3840&q=75)
![Etomidate Acid (1-[(1R)-1-Phenylethyl]-1H-imidazole-5-carboxylic Acid)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F61%2Fthumb-webp%2FFOR1264.04.webp&w=3840&q=75)
